Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02262000 · ClinicalTrials.gov registry record · NA
Phase II Image Guided Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer
A NA study, sponsored by West Virginia University.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT02262000 is a NA study that was terminated before completion, run by West Virginia University. The registered enrollment target is 3 participants.
The verdict
NCT02262000, a NA study, was terminated before completion, sponsored by West Virginia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study will help researchers learn about the best dose of radiation to be used when treating large early stage non-small cell lung cancer (NSCLC) with a treatment called stereotactic ablative radiotherapy (SABR). Current treatments with SABR for early stage NSCLC show positive response. But, for large early stage NSCLC it may be better to give different SABR doses than what is used in routine early stage NSCLC treatment. It is not understood which dose is best for treating large early stage NSCLC. Therefore, this study can help researchers learn if giving a higher dose using SABR over a period of 5-10 treatment days can increase the chance of cure for large early stage NSCLC.
Interventions
- RADIATION Image Guided Stereotactic Ablative Radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2013-09 |
| Est. Completion | 2017-07-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02262000
The ClinicalTrials.gov registry entry for NCT02262000 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is West Virginia University, which has 122 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Image Guided Stereotactic Ablative Radiotherapy is the first listed.
NCT02262000 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02262000 about?
NCT02262000 is a clinical study titled "Phase II Image Guided Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer". This study will help researchers learn about the best dose of radiation to be used when treating large early stage non-small cell lung cancer (NSCLC) with a treatment called stereotactic ablative radiotherapy (SABR). Current treatments with SABR for early stage NSCLC show positive response. But, for...
What is the current status of trial NCT02262000?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2013-09. Estimated completion is 2017-07-10.
What interventions are being tested in trial NCT02262000?
The interventions under investigation include: Image Guided Stereotactic Ablative Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT02262000?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.